REPORT ID 2152

Global Over The Counter (OTC) Drugs Market Professional Survey Report 2017

Publish Date
7-Dec-17
Pages
108
Format
Electronic (PDF)

This report studies Over The Counter (OTC) Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Bayer
    GlaxoSmithKline
    Johnson & Johnson
    Pfizer
    Sanofi
    Eli Lilly & Company
    Merck & Co Inc
    AstraZeneca
    Abbott Laboratories
    Bristol-Myers Squibb Company

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Branded Drugs
    Generic Drugs

By Application, the market can be split into
    Pharmacies
    Grocery Stores
    Vitamin and Health Food Stores
    Online Pharmacies
    Others

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Over The Counter (OTC) Drugs Market Professional Survey Report 2017
1 Industry Overview of Over The Counter (OTC) Drugs
    1.1 Definition and Specifications of Over The Counter (OTC) Drugs
        1.1.1 Definition of Over The Counter (OTC) Drugs
        1.1.2 Specifications of Over The Counter (OTC) Drugs
    1.2 Classification of Over The Counter (OTC) Drugs
        1.2.1 Branded Drugs
        1.2.2 Generic Drugs
    1.3 Applications of Over The Counter (OTC) Drugs
        1.3.1 Pharmacies
        1.3.2 Grocery Stores
        1.3.3 Vitamin and Health Food Stores
        1.3.4 Online Pharmacies
        1.3.5 Others
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Over The Counter (OTC) Drugs
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Over The Counter (OTC) Drugs
    2.3 Manufacturing Process Analysis of Over The Counter (OTC) Drugs
    2.4 Industry Chain Structure of Over The Counter (OTC) Drugs

3 Technical Data and Manufacturing Plants Analysis of Over The Counter (OTC) Drugs
    3.1 Capacity and Commercial Production Date of Global Over The Counter (OTC) Drugs Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Over The Counter (OTC) Drugs Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Over The Counter (OTC) Drugs Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Over The Counter (OTC) Drugs Major Manufacturers in 2016

4 Global Over The Counter (OTC) Drugs Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Over The Counter (OTC) Drugs Capacity and Growth Rate Analysis
        4.2.2 2016 Over The Counter (OTC) Drugs Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Over The Counter (OTC) Drugs Sales and Growth Rate Analysis
        4.3.2 2016 Over The Counter (OTC) Drugs Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Over The Counter (OTC) Drugs Sales Price
        4.4.2 2016 Over The Counter (OTC) Drugs Sales Price Analysis (Company Segment)

5 Over The Counter (OTC) Drugs Regional Market Analysis
    5.1 North America Over The Counter (OTC) Drugs Market Analysis
        5.1.1 North America Over The Counter (OTC) Drugs Market Overview
        5.1.2 North America 2012-2017E Over The Counter (OTC) Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Over The Counter (OTC) Drugs Sales Price Analysis
        5.1.4 North America 2016 Over The Counter (OTC) Drugs Market Share Analysis
    5.2 China Over The Counter (OTC) Drugs Market Analysis
        5.2.1 China Over The Counter (OTC) Drugs Market Overview
        5.2.2 China 2012-2017E Over The Counter (OTC) Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Over The Counter (OTC) Drugs Sales Price Analysis
        5.2.4 China 2016 Over The Counter (OTC) Drugs Market Share Analysis
    5.3 Europe Over The Counter (OTC) Drugs Market Analysis
        5.3.1 Europe Over The Counter (OTC) Drugs Market Overview
        5.3.2 Europe 2012-2017E Over The Counter (OTC) Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Over The Counter (OTC) Drugs Sales Price Analysis
        5.3.4 Europe 2016 Over The Counter (OTC) Drugs Market Share Analysis
    5.4 Southeast Asia Over The Counter (OTC) Drugs Market Analysis
        5.4.1 Southeast Asia Over The Counter (OTC) Drugs Market Overview
        5.4.2 Southeast Asia 2012-2017E Over The Counter (OTC) Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Over The Counter (OTC) Drugs Sales Price Analysis
        5.4.4 Southeast Asia 2016 Over The Counter (OTC) Drugs Market Share Analysis
    5.5 Japan Over The Counter (OTC) Drugs Market Analysis
        5.5.1 Japan Over The Counter (OTC) Drugs Market Overview
        5.5.2 Japan 2012-2017E Over The Counter (OTC) Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Over The Counter (OTC) Drugs Sales Price Analysis
        5.5.4 Japan 2016 Over The Counter (OTC) Drugs Market Share Analysis
    5.6 India Over The Counter (OTC) Drugs Market Analysis
        5.6.1 India Over The Counter (OTC) Drugs Market Overview
        5.6.2 India 2012-2017E Over The Counter (OTC) Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Over The Counter (OTC) Drugs Sales Price Analysis
        5.6.4 India 2016 Over The Counter (OTC) Drugs Market Share Analysis

6 Global 2012-2017E Over The Counter (OTC) Drugs Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Over The Counter (OTC) Drugs Sales by Type
    6.2 Different Types of Over The Counter (OTC) Drugs Product Interview Price Analysis
    6.3 Different Types of Over The Counter (OTC) Drugs Product Driving Factors Analysis
        6.3.1 Branded Drugs of Over The Counter (OTC) Drugs Growth Driving Factor Analysis
        6.3.2 Generic Drugs of Over The Counter (OTC) Drugs Growth Driving Factor Analysis

7 Global 2012-2017E Over The Counter (OTC) Drugs Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Over The Counter (OTC) Drugs Consumption by Application
    7.2 Different Application of Over The Counter (OTC) Drugs Product Interview Price Analysis
    7.3 Different Application of Over The Counter (OTC) Drugs Product Driving Factors Analysis
        7.3.1 Pharmacies of Over The Counter (OTC) Drugs Growth Driving Factor Analysis
        7.3.2 Grocery Stores of Over The Counter (OTC) Drugs Growth Driving Factor Analysis
        7.3.3 Vitamin and Health Food Stores of Over The Counter (OTC) Drugs Growth Driving Factor Analysis
        7.3.4 Online Pharmacies of Over The Counter (OTC) Drugs Growth Driving Factor Analysis
        7.3.5 Others of Over The Counter (OTC) Drugs Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Over The Counter (OTC) Drugs
    8.1 Bayer
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Bayer 2016 Over The Counter (OTC) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Bayer 2016 Over The Counter (OTC) Drugs Business Region Distribution Analysis
    8.2 GlaxoSmithKline
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 GlaxoSmithKline 2016 Over The Counter (OTC) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 GlaxoSmithKline 2016 Over The Counter (OTC) Drugs Business Region Distribution Analysis
    8.3 Johnson & Johnson
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Johnson & Johnson 2016 Over The Counter (OTC) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Johnson & Johnson 2016 Over The Counter (OTC) Drugs Business Region Distribution Analysis
    8.4 Pfizer
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Pfizer 2016 Over The Counter (OTC) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Pfizer 2016 Over The Counter (OTC) Drugs Business Region Distribution Analysis
    8.5 Sanofi
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Sanofi 2016 Over The Counter (OTC) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Sanofi 2016 Over The Counter (OTC) Drugs Business Region Distribution Analysis
    8.6 Eli Lilly & Company
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Eli Lilly & Company 2016 Over The Counter (OTC) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Eli Lilly & Company 2016 Over The Counter (OTC) Drugs Business Region Distribution Analysis
    8.7 Merck & Co Inc
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Merck & Co Inc 2016 Over The Counter (OTC) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Merck & Co Inc 2016 Over The Counter (OTC) Drugs Business Region Distribution Analysis
    8.8 AstraZeneca
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 AstraZeneca 2016 Over The Counter (OTC) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 AstraZeneca 2016 Over The Counter (OTC) Drugs Business Region Distribution Analysis
    8.9 Abbott Laboratories
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Abbott Laboratories 2016 Over The Counter (OTC) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Abbott Laboratories 2016 Over The Counter (OTC) Drugs Business Region Distribution Analysis
    8.10 Bristol-Myers Squibb Company
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Bristol-Myers Squibb Company 2016 Over The Counter (OTC) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Bristol-Myers Squibb Company 2016 Over The Counter (OTC) Drugs Business Region Distribution Analysis

9 Development Trend of Analysis of Over The Counter (OTC) Drugs Market
    9.1 Global Over The Counter (OTC) Drugs Market Trend Analysis
        9.1.1 Global 2017-2022 Over The Counter (OTC) Drugs Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Over The Counter (OTC) Drugs Sales Price Forecast
    9.2 Over The Counter (OTC) Drugs Regional Market Trend
        9.2.1 North America 2017-2022 Over The Counter (OTC) Drugs Consumption Forecast
        9.2.2 China 2017-2022 Over The Counter (OTC) Drugs Consumption Forecast
        9.2.3 Europe 2017-2022 Over The Counter (OTC) Drugs Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Over The Counter (OTC) Drugs Consumption Forecast
        9.2.5 Japan 2017-2022 Over The Counter (OTC) Drugs Consumption Forecast
        9.2.6 India 2017-2022 Over The Counter (OTC) Drugs Consumption Forecast
    9.3 Over The Counter (OTC) Drugs Market Trend (Product Type)
    9.4 Over The Counter (OTC) Drugs Market Trend (Application)

10 Over The Counter (OTC) Drugs Marketing Type Analysis
    10.1 Over The Counter (OTC) Drugs Regional Marketing Type Analysis
    10.2 Over The Counter (OTC) Drugs International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Over The Counter (OTC) Drugs by Region
    10.4 Over The Counter (OTC) Drugs Supply Chain Analysis

11 Consumers Analysis of Over The Counter (OTC) Drugs
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Over The Counter (OTC) Drugs Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source